Relmada Therapeutics, Inc. (RLMD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 3.8200 |
| Open | 3.7506 |
| Bid | 3.8200 x 400 |
| Ask | 3.8800 x 400 |
| Day's Range | 3.7506 - 3.9500 |
| 52 Week Range | 2.3600 - 7.2230 |
| Volume | |
| Avg. Volume | 172,486 |
| Market Cap | 115.567M |
| Beta (5Y Monthly) | 0.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GuruFocus.com
Relmada Therapeutics Inc (RLMD) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key financial outcomes and strategic updates from Relmada Therapeutics' first quarter of 2024, emphasizing advancements in clinical trials and operational efficiencies.
- Insider Monkey
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
- Thomson Reuters StreetEvents
Q4 2023 Relmada Therapeutics Inc Earnings Call
Q4 2023 Relmada Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.